Rocket Pharma Shares Sink Despite Winning FDA Approval for Rare Childhood Disease

Rocket Pharma Shares Sink Despite Winning FDA Approval for Rare Childhood Disease

The approval that disappointed investors Rocket Pharma received FDA approval for a new treatment targeting a rare childhood disorder, yet the company...